Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
IBM
IBM
|
+$320M |
| 2 |
Johnson & Johnson
JNJ
|
+$221M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Walt Disney
DIS
|
+$154M |
| 5 |
Target
TGT
|
+$145M |
Top Sells
| 1 |
Apple
AAPL
|
+$283M |
| 2 |
Eli Lilly
LLY
|
+$203M |
| 3 |
Microsoft
MSFT
|
+$199M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$194M |
| 5 |
Citigroup
C
|
+$177M |
Sector Composition
| 1 | Technology | 14.01% |
| 2 | Healthcare | 12.1% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Consumer Staples | 11.91% |
| 5 | Industrials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CEDU
2376
DELISTED
CHINAEDU CORPORATION ADS
CEDU
| $402K | ﹤0.01% |
57,500
| – | – |
|
2377
Photronics
PLAB
$1.3B
| $399K | ﹤0.01% |
50,900
-48,900
| -49% | -$383K |
|
|
MILL
2378
DELISTED
MILLER ENERGY RESOURCES, INC COM STK
MILL
| $399K | ﹤0.01% |
+55,000
| New | +$399K |
|
|
CRT
2379
Cross Timbers Royalty Trust
CRT
$48.5M
| $396K | ﹤0.01% |
13,500
-2,154
| -14% | -$63.2K |
|
2380
Cross Country Healthcare
CCRN
$455M
| $395K | ﹤0.01% |
65,420
-30,607
| -32% | -$185K |
|
|
HAST
2381
DELISTED
HASTINGS ENTERTAINMENT INC
HAST
| $395K | ﹤0.01% |
156,300
+4,100
| +3% | +$10.4K |
|
|
CRAY
2382
DELISTED
Cray, Inc.
CRAY
| $392K | ﹤0.01% |
16,300
-235,500
| -94% | -$5.66M |
|
|
SBR
2383
Sabine Royalty Trust
SBR
$1.13B
| $392K | ﹤0.01% |
+7,700
| New | +$392K |
|
2384
Insteel Industries
IIIN
$745M
| $390K | ﹤0.01% |
24,240
+13,274
| +121% | +$214K |
|
|
DGAS
2385
DELISTED
Delta Natural Gas Co Inc
DGAS
| $389K | ﹤0.01% |
+17,600
| New | +$389K |
|
|
EDG
2386
DELISTED
EDGEN GROUP INC CLASS A COM STK
EDG
| $389K | ﹤0.01% |
+51,200
| New | +$389K |
|
|
ANDV
2387
DELISTED
Andeavor
ANDV
| $387K | ﹤0.01% |
8,800
-200,700
| -96% | -$8.83M |
|
2388
Granite Construction
GVA
$4.8B
| $386K | ﹤0.01% |
12,600
-172,500
| -93% | -$5.28M |
|
|
LNBB
2389
DELISTED
L N B BANCORP INC
LNBB
| $386K | ﹤0.01% |
41,100
+6,900
| +20% | +$64.8K |
|
2390
Shore Bancshares
SHBI
$567M
| $385K | ﹤0.01% |
43,800
+2,500
| +6% | +$22K |
|
2391
TechTarget
TTGT
$404M
| $383K | ﹤0.01% |
76,900
-19,900
| -21% | -$99.1K |
|
|
AMID
2392
DELISTED
American Midstream Partners, LP
AMID
| $383K | ﹤0.01% |
19,200
+2,400
| +14% | +$47.9K |
|
|
QLTY
2393
DELISTED
QUALITY DISTR INC FLA
QLTY
| $383K | ﹤0.01% |
+41,500
| New | +$383K |
|
|
ETRM
2394
DELISTED
EnteroMedics Inc.
ETRM
| $382K | ﹤0.01% |
+292
| New | +$382K |
|
2395
Assembly Biosciences
ASMB
$171M
| $381K | ﹤0.01% |
2,198
-984
| -31% | -$171K |
|
2396
US Energy Corp
USEG
$38.4M
| $380K | ﹤0.01% |
3,003
-640
| -18% | -$81K |
|
|
GSB
2397
DELISTED
GlobalSCAPE, Inc.
GSB
| $378K | ﹤0.01% |
236,500
+3,800
| +2% | +$6.07K |
|
|
OTIV
2398
DELISTED
OTI On Track Innovations Ltd
OTIV
| $376K | ﹤0.01% |
238,200
+9,900
| +4% | +$15.6K |
|
2399
Allient
ALNT
$774M
| $375K | ﹤0.01% |
69,600
+12,000
| +21% | +$64.7K |
|
|
SCR
2400
DELISTED
SIMCERE PHARMACEUTICAL GROUP, ADS
SCR
| $375K | ﹤0.01% |
39,600
+11,800
| +42% | +$112K |
|